Summary
The post-mortem brain concentrations of dopamine (DA) and homo-vanillic acid (HVA) were determined in 16 parts of the brain from patients with no history of neurologic or psychiatric illness. Fifteen men and nine women, with a mean age of 61.0±18.7 years (range 23–92 years) were included. They had died from either ischaemic heart disease or cancer. In the post-mortem investigation several factors were controlled: age, time between death and autopsy, time between autopsy and chemical analysis and storage time (−20 °C).
The DA concentrations in the different brain areas were found to be positively intercorrelated, especially those in the basal ganglia, hippocampus and the mesencephalon. The HVA concentrations measured in various cortical structures were also positively intercorrelated. In several regions of the brain there was a significant inverse correlation between the DA and HVA concentrations.
The DA and HVA concentrations did not differ according to sex, but age had a marked influence on the DA concentration. Significant decrease with age was observed in the nucleus caudatus, globus pallidus, mesencephalon, hippocampus and in the cortex gyrus hippocampus. These findings are discussed in relation to the effect of aging neurons.
A review of human post-mortem investigations on DA and HVA concentrations is also presented.
Similar content being viewed by others
References
Adolfsson, R., Gottfries, C.-G., Winblad, B. Monoaminer och monoamin-metaboliter vid senil demens. In: Nordisk Gerontologi (Steen, B., Svanborg, A., eds.), pp. 60–63. Södertälje: Astra AB. 1975.
Adolfsson, R., Gottfries, C.-G., Winblad, B.: Methodological aspects of postmortem investigations of human brain-with special reference to monoamines and related enzymes. Presented at 10. CINP-meeting, Quebec, Canada, July 4–9, 1976. (In press, 1978.)
Alfrey, A. C., Mishell, J. M., Burks, J., Contiguglia, S. R., Rudolph, H., Lewin, E., Holmes, J. H. Dialysis dementia. Trans. Am. Soc. artif. intern. Org.18, 257–260 (1972).
Algeri, S., Ponzio, F., Bonati, M., Brunello, N.: Biochemical changes in monoaminergic neurons in the CNS of the senescent rat. Presented at 10. CINP-meeting, Quebec, Canada, July 4–9, 1976. (In press, 1978.)
Andén, N.-E., Roos, B.-E., Werdinius, B. On the occurrence of homo-vanillic acid in brain and cerebrospinal fluid and its determination by a fluorimetric method. Life Sci.2, 448–458 (1963).
Andén, N.-E., Carlsson, A., Dahlström, A., Fuxe, K., Hillarp, N. Å. Demonstration and mapping out of nigro-striatal dopamine neurons. Life Sci.3, 523–530 (1964).
Andén, N.-E., Dahlström, A., Fuxe, K., Larsson, K. Mapping out of catecholamine and 5-hydroxytryptamine neurons innervating the telencephalon and diencephalon. Life Sci.4, 1275–1279 (1965).
Andén, N.-E., Dahlström, A., Fuxe, K., Larsson, L., Olsson, L., Unger-stedt, U. Ascending monoamine neurons to the telencephalon and diencephalon. Acta psychiat. Scand.67, 313–326 (1966).
Andén, N.-E., Carlsson, A., Häggendahl, J. Adrenergic mechanisms. Ann. Rev. Pharmacol.9, 119–134 (1969).
Anton, A. H., Sayre, D. F. Distribution of dopamine and DOPA in various animals and a method for their determination in diverse biological material. J. Pharmacol. Exp. Ther.145, 326–336 (1964).
Bernheimer, H., Birkmayer, W., Hornykiewicz, O. Zur Biochemie des Parkinson-Syndroms des Menschen. Klin. Wschr.41, 465–469 (1963).
Bernheimer, H. Distribution of homovanillic acid in the human brain. Nature204, 587–588 (1964).
Bernheimer, H., Hornykiewicz, O. Herabgesetzte Konzentration der Homovanillinsäure im Gehirn von parkinsonkranken Menschen als Ausdruck der Störung des zentralen Dopaminstoffwechsels. Klin. Wschr.43, 711–715 (1965).
Bertler, Å., Carlsson, A., Rosengren, E. A method for the fluorimetric determination of adrenaline and noradrenaline in tissue. Acta physiol. scand.44, 273–292 (1958).
Bertler, Å., Rosengren, E. Occurrence and distribution of catecholamines in brain. Acta physiol. scand.47, 350–361 (1959).
Bertler, Å. Occurrence and localization of catecholamines in the human brain. Acta physiol. scand.51, 97–107 (1961).
Birkmayer, W., Danielczyk, W., Neumayer, E., Riederer, P. Nucleus ruber and l-dopa psychosis: Biochemical post-mortem findings. J. Neural Transm.35, 93–116 (1974).
Bird, E. D., Iversen, L. L. Huntington's Chorea. Post-mortem measurement of glutamic acid decarboxylase, choline acetyltransferase and dopamine in basal ganglia. Brain97, 457–472 (1974).
Bloom, F. E., Giarman, N. J. Physiologic and pharmacologic considerations of biogenic amines in nervous system. Am. Rev. Pharmacol.8, 229–258 (1968).
Bowen, D. M., Smith, C. B., White, P., Davison, A. N. Neurotransmitterrelated enzymes and indices of hypoxia in senile dementia and other abiothropies. Brain99, 459–496 (1976).
Brizze, K. R., Harkin, J. C., Ordy, M. J., Kaack, B. Accumulation and distribution of lipofuscin, amyloid, and senile plaque in the aging nervous system. In: Aging (Brody, H., Harman, D., Ordy, J. M., eds.), pp. 39–78. New York: Raven Press. 1975.
Brody, H. Organization of the cerebral cortex. A study of aging in the human cerebral cortex. J. comp. neurol.102, 511–556 (1955).
Brown, R. M., Kehr, W., Carlsson, A. Functional and biochemical aspects of catecholamine metabolism in brain under hypoxia. Brain Res.85, 491–509 (1975).
Carlsson, A., Waldeck, B. A fluorimetric method for the determination of dopamine (3-hydroxytyramine). Acta physiol. scand.44, 293–298 (1958).
Carlsson, A., Lindqvist, M. In vivo decarboxylation ofα-methyldopa andα-methyl-meta-tyrosine. Acta physiol. scand.54, 87–94 (1962).
Carlsson, A. Basic actions of psychoactive drugs. Int. J. Neurol.6, 27–47 (1967).
Carlsson, A., Winblad, B. Influence of age and time interval between death and autopsy on dopamine and 3-methoxytyramine levels in human basal ganglia. J. Neural Transm.38, 271–276 (1976).
Chase, T. N., Bulch, T. S., Jacobowitz, D. M. Dopamine histofluorescence in post-mortem specimens of human and rat striatum. J. psych. Res.11, 281–282 (1974).
Constantinidis, J., Tissot, R., de la Torre, J. C., Geissbuhler, F. Essai de localisation des monoamines dans l'hypothalamos human. Path, et Biol.17, 361–363 (1969).
Coté, J., Kremzner, L. T.: Age-dependent changes in the activities of enzymes related to the formation and degradation of neurotransmitters in human brain: correlation with the levels of polyamines. Abstr. Am. Soc. Neurochem., p. 83 (1974).
Dahlström, A., Fuxe, K. Evidence for the existence of monoamine-containing neurons in the central nervous system. Acta physiol. scand.62, Suppl. 232, 1–55 (1964).
Davis, J. M. Theories of biologicaletiology of affective disorders. Int. rev. Neurobiol.12, 145–175 (1970).
Dayan, A. D. Quantitative histological studies on the aged human brain. Acta neuropath. (Berl.)16, 95–102 (1970).
Domino, E. F., Krause, R. R., Bowers, J. Various enzymes involved with putative neurotransmitters. Arch. Gen. Psychiat.29, 195–201 (1973).
Ehringer, H., Hornykiewicz, O. Verteilung von Noradrenaline im Dopamin (3-hydroxytyramin) im Gehirn des Menschen und ihr Verhalten bei Erkrankungen des extrapyramidalen Systems. Klin. Wschr.38, 1236–1240 (1960).
Euler, U. S. v., Floding, I. Fluorimetric estimation of noradrenaline and adrenaline in urine. Acta physiol. scand.33, Suppl. 118, 57–62 (1955).
Fahn, S., Libsch, L. R., Cutler, R. W. Monoamines in the human neostriatum. Topographic distribution in normals and in Parkinson's disease and their role in akinesia, rigidity, chorea and tremor. J. neurol. Sci.14, 427–455 (1971).
Finch, C. E. Catecholamine metabolism in the brains of aging male mice. Brain Res.52, 262–276 (1973).
Fuxe, K., Hökfelt, T., Ungerstedt, U.: Localization of monoamines in the central nervous system. In: Monoamines noyaux gris centraux et syndrome de Parkinson (Ajuriaguerra, De J., Cauttier, G., eds.), pp. 23–60 (1971).
Ganroth, P. O., Rosengren, D., Gottfries, C.-G. Effect of iproniazid on monoamines and monoamine oxidase in human brain. Exp.18, 260–261 (1962).
Gessa, G. L., Biggio, G., Vargiu, L., Napoleona, F., Tagliamonte, A. Norepinephrine and dopamine concentrations in the cerebral cortex of man. Exp.30, 1295–1296 (1974).
Gottfries, C.-G., Rosengren, A. M., Rosengren, E. The occurrence of homovanillic acid in human brain. Acta Pharmacol. Toxicol.23, 23–40 (1965).
Gottfries, C.-G., Gottfries, I., Roos, B.-E. The investigation of homovanillic acid in the human brain and its correlation to senile dementia. Brit. J. Psychiat.115, 563–574 (1969).
Gottfries, C.-G., Roos, B.-E., Winblad, B. Determination of 5-hydroxytryptamine, 5-hydroxyindoleacetic acid and homovanillic acid in brain tissue from an autopsy material. Acta psychiat. scand.50, 496–507 (1974).
Hornykiewicz, O., Lisch, H. J., Springer, A. Homovaniilic acid in different regions of the human brain: Attempt at localizing central dopamine fibres. Brain Res.11, 662–671 (1968).
Hökfelt, T., Ungerstedt, U. Electron- and fluorescence microscopy on the nucleus caudatus and putamen of the rat after unilateral lesions on ascending nigro-neostriatal dopamine neurons. Acta physiol. scand.76, 415–426 (1969).
Hökfelt, T., Ljungdahl, Å., Fuxe, K., Johansson, O. Dopamine nerve terminals in the rat limbic cortex: Aspects of the dopamine hypothesis of schizophrenia. Science184, 177–179 (1974).
Jacobsson, L., Ottosson, J.-O. Initial mental disorders in carcinoma of pancreas and stomach. Acta psychiat. scand. Suppl.221, 120–127 (1971).
Jellinger, K., Riederer, P. Brain monoamines in metabolic (endotoxic) coma. A preliminary biochemical study in human post-mortem material. J. Neural Transm.41, 275–286 (1977).
Knell, A. J., Davidson, A. R., Williams, R., Kantamaneni, B. D., Curzon, G. Dopamine and serotonin metabolism in hepatic encephalopathy. Brit. J. Med.1, 549–551 (1974).
Korf, J., Roos, B.-E., Werdinius, B. Fluorometric determination of homovanillic acid (HVA) in tissues using unoin exchange separation and mixed solvent elimination. Acta chem. scand.25, 333–335 (1971).
Laverty, R., Taylor, K. M. The fluorometric assay of catecholamines and related compounds. Anal. Biochem.22, 269–279 (1968).
Lloyd, K. G., Hornykiewicz, O. Occurrence and distribution of aromatic L-amino acid (L-dopa) decarboxylase in the human brain. J. Neurochem.19, 1549–1559 (1972).
Lloyd, K. G., Davidson, L., Hornykiewicz, O. The neurochemistry of Parkinson's disease: Effect of l-dopa therapy. J. Pharm. Exp. Ther.195, No. 3, 453–464 (1975).
Mattsson, B., Gottfries, C.-G., Roos, B.-E., Winblad, B. Huntington's chorea. Pathology and brain amines. Acta psychiat. scand. Suppl.255, 269–277 (1974).
McGeer, E. G., McGeer, P. L., Wada, J. A. Distribution of tyrosine hydroxylase in human and animal brain. J. Neurochem.18, 1647–1658 (1971).
McGeer, P. L., McGeer, E. G. Enzymes associated with the metabolism of catecholamines, acetylcholine and GABA in human controls and patients with Parkinson's disease and Huntington's chorea. J. Neurochem.25, 65–76 (1976).
Molinoff, P. B., Axelrod, J. Biochemistry of catecholamines. Ann. rev. Biochem.40, 465–500 (1971).
Olsson, L., Nyström, B., Seizer, Å. Monoamine fluorescence histochemistry of human post-mortem brain. Brain Res.63, 231–247 (1973).
Quello, A. C., Hiely, R., Iversen, L. L. Use of catechol-O-transferase for the enzyme radiochemical assay of dopamine. J. Neurochem.21, 1337 to 1340 (1973).
Riederer, P., Wuketich, S. Time course of nigrostriatal degeneration in Parkinson's disease. J. Neural Transm.38, 277–301 (1976).
Rinne, U. K., Sonninen, V. The occurrence of dopamine and noradrenaline in the tuberohypophyseal system. Exp.24, 177–178 (1968).
Rinne, U. K., Sonninen, V. Brain catecholamines and their metabolites in Parkinsonian patients. Arch. Neurol.28, 107–110 (1973).
Robinson, D. S., Sourkes, T. L., Nies, A., Harris, L. S., Spector, S., Barlett, D. K., Kaye, I. S. Monoamine metabolism in human brain. Arch. Gen. Psychiat.34, 89–92 (1977).
Samorajski, T. How the human brain responds to aging. J. Am. Ger. Soc.24, No. 1, 4–11 (1975).
Sano, I., Taniguchi, K., Gamo, T., Takesada, M., Kakimoto, Y. Die Katechinamine im Zentralnervensystem. Klin. Wschr.38, 57–62 (1960).
Scheibel, M. E., Scheibel, A. B. Structural changes in the aging brain. In: Aging (Brody, H., Harman, D., Ordy, J. M., eds.), pp. 11–37. New York: Raven Press. 1975.
Schildkraut, J. J., Kety, S. S. Biogenic amines and emotion. Science156, 21–30 (1967).
Sharman, D. F. A fluorimetric method for the estimation of 4-hydroxy-3-methoxyphenylacetic acid (homovanillic acid) and its identification in brain tissue. Brit. J. Pharmacol.20, 204–213 (1963).
Snyder, S. H., Banerjee, S. O., Yamamura, H. I., Greenberg, D. Drugs neurotransmitter and schizophrenia. Sci.184, 1243–1253 (1974).
Thierry, A. M., Stinus, L., Blanc, G., Glowinski, J. Some evidence for the existence of dopaminergic neurons in the rat cortex. Brain Res.50, 230–234 (1973).
Tomlinson, B. E., Blessed, G., Roth, M. Observations on the brains of nondemented old people. J. neurol. Sci.7, 331–356 (1968).
de la Torre, J. C. Catecholamines in the human diencephalon: A histochemical fluorescence study. Acta neuropath. (Berl.)21, 165–168 (1972).
Ungerstedt, U. Stereotaxic mapping of the monoamine pathways in the rat brain. Acta physiol. scand. Suppl.376, 1–48 (1971).
Wardle, E. N. Dialysis dementia. Lancet2, 47 (1973).
Weil-Malherbe, H., Bone, A. D. The chemical estimation of adrenaline-like substances in blood. Biochem. J.51, 311–313 (1952).
Wiesel, F. A., Sedvall, G. Post-mortal changes of dopamine and homovanillic acid levels in rat striatum as measured by massphragmentography. Brain Res.65, 547–550 (1974).
Vogel, W. H., Orfei, V., Century, B. Activities of enzymes involvement in the formation and distriction of biogenic amines in various areas of human brain. J. Pharmac. exp. Ther.165, 196–203 (1969).
World Federation of Neurology Collaborative study of epidemiological factors in cerebral vascular disease. Coding Guide. Antwerpen (1959).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Adolfsson, R., Gottfries, C.G., Roos, B.E. et al. Post-mortem distribution of dopamine and homo-vanillic acid in human brain, variations related to age, and a review of the literature. J. Neural Transmission 45, 81–105 (1979). https://doi.org/10.1007/BF01250085
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF01250085